Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-21

FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (BIOCON PHARMA INC.)

View source ↗

Summary

FDA approved Biocon Pharma Inc. for an Original Application of norepinephrine bitartrate (norepinephrine bitartrate) as a generic product. It is a vasopressor u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)